You are here

  • Home
  • Archive
  • Volume 95, Issue 5
  • Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial

Article info

Article menu
Download PDFPDF
Original article
Endothelial function
Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial

Authors

  1. Professor R Weber, Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland; Rainer.Weber{at}usz.ch
View Full Text

Citation

Flammer AJ, Vo NTT, Ledergerber B, et al
Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial
Heart 2009;95:385-390.

Publication history

  • Accepted June 24, 2008
  • First published July 24, 2008.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and British Cardiac Society